Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Allylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel asymmetric synthesis route for dihydroxyisoleucine derivatives ensures high optical purity and scalable production for global pharmaceutical supply chains.
Patent CN118530134A reveals Pd/Cu catalysis for axial chirality. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel zinc-promoted asymmetric allylation for DPPIV inhibitors. High stereoselectivity, scalable route for API intermediates.
Patent CN112010910B details a novel iridium-catalyzed synthesis of chiral ferrocene homoallylamines, offering high yields and enantioselectivity for cost-effective pharmaceutical intermediate manufacturing.
Patent CN1774421A reveals a novel RCM-based route for Atorvastatin intermediates, offering significant cost reduction in pharmaceutical manufacturing and enhanced supply chain reliability.
Patent CN1639172A details novel silicon-based reagents for high-ee alcohol synthesis, offering scalable routes for complex pharmaceutical intermediates manufacturing.
Patent CN116478081A reveals novel monodentate phosphine ligands for palladium-catalyzed asymmetric allylation. Achieve high enantioselectivity and yield for reliable pharmaceutical intermediate supply chains.
Novel chiral allylation method for Me-tapentadol intermediates. High ee, scalable process for reliable pharmaceutical intermediate supply chain.
Patent CN117209399A reveals iridium-catalyzed synthesis avoiding toxic cyanide. Delivers high purity chiral allene nitriles with significant supply chain and cost advantages.
Novel asymmetric synthesis method for high-purity amino acid intermediates. Reduces cost and improves supply chain reliability for pharmaceutical manufacturing.
Novel magnesium-catalyzed asymmetric allylation for Sitagliptin intermediate. Reduces cost and improves supply chain reliability for pharmaceutical manufacturers.
Patent CN104892472A details a novel bis-chiral sulfoxide-alkene ligand synthesis enabling high-efficiency rhodium-catalyzed asymmetric allylation for pharmaceutical intermediate manufacturing.
Patent CN112759595B details a novel Pd-catalyzed asymmetric allylation for chiral nucleosides, offering high enantioselectivity and streamlined manufacturing for pharmaceutical intermediates.
Novel asymmetric trifluoromethyl allylation method enables high-yield pyrazolone production with superior stereoselectivity for pharmaceutical manufacturing.
Novel axial chiral phosphine-ene ligand enables mild-condition asymmetric allylation with high yield and enantioselectivity, ensuring reliable supply chain for pharmaceutical intermediates.
Novel axial chiral phosphine-ene ligand enables high-yield asymmetric allylation with mild conditions, reducing manufacturing costs and lead times for fine chemicals.